Raltitrexed

Key facts

Invented name
Tomudex
Active substance
Raltitrexed
Therapeutic area
Oncology
Decision number
P/17/2009
PIP number
Raltitrexed
Pharmaceutical form(s)
Powder for solution for injection or infusion
Condition(s) / indication(s)
Mesothelioma of the pleura
Route(s) of administration
Intravenous use
Contact for public enquiries
Applicant: Hospira UK Limited
E-mail: medinfouk@hospira.com
Country: United Kingdom
Phone: +44 1926821010
Fax: +44 1926834446
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating